share_log

Medical Properties Trust Inc | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(14.9%)

Medical Properties Trust Inc | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(14.9%)

Medical Properties Trust | SC 13G/A：超過5%持股股東披露文件(修正)-BlackRock, Inc.(14.9%)
美股SEC公告 ·  11/08 14:28

Moomoo AI 已提取核心訊息

On September 30, 2024, BlackRock, Inc. filed an amended Schedule 13G/A with the SEC, indicating a significant ownership stake in Medical Properties Trust Inc. The filing revealed that BlackRock now beneficially owns 89,509,007 shares of Medical Properties Trust, representing 14.9% of the company's common stock. This position reflects BlackRock's sole voting power over 86,853,098 shares and sole dispositive power over the entire 89,509,007 shares. The filing was made in accordance with Rule 13d-1(b) under the Securities Exchange Act of 1934, which applies to parent holding companies or control persons. The address of BlackRock's principal business office is listed as 50 Hudson Yards, New York, NY 10001. Medical Properties Trust Inc., headquartered in Birmingham, AL, is the issuer of the common stock in question. The filing also notes that the iShares Core S&P Small-Cap ETF, managed by BlackRock, holds more than five percent of Medical Properties Trust's outstanding common stock. The disclosure was signed by Spencer Fleming, Attorney-In-Fact for BlackRock, Inc., on November 8, 2024.
On September 30, 2024, BlackRock, Inc. filed an amended Schedule 13G/A with the SEC, indicating a significant ownership stake in Medical Properties Trust Inc. The filing revealed that BlackRock now beneficially owns 89,509,007 shares of Medical Properties Trust, representing 14.9% of the company's common stock. This position reflects BlackRock's sole voting power over 86,853,098 shares and sole dispositive power over the entire 89,509,007 shares. The filing was made in accordance with Rule 13d-1(b) under the Securities Exchange Act of 1934, which applies to parent holding companies or control persons. The address of BlackRock's principal business office is listed as 50 Hudson Yards, New York, NY 10001. Medical Properties Trust Inc., headquartered in Birmingham, AL, is the issuer of the common stock in question. The filing also notes that the iShares Core S&P Small-Cap ETF, managed by BlackRock, holds more than five percent of Medical Properties Trust's outstanding common stock. The disclosure was signed by Spencer Fleming, Attorney-In-Fact for BlackRock, Inc., on November 8, 2024.
2024年9月30日，貝萊德公司向SEC提交了修訂後的13G/A表，顯示其在醫療物業信託公司擁有重要的所有權股份。提交的文件顯示，貝萊德現在有利地擁有醫療物業信託公司的89,509,007股股份，佔公司普通股的14.9%。該持倉反映了貝萊德對86,853,098股股份的獨家表決權和對整個89,509,007股股份的獨家處置權。該提交是根據1934年證券交易法第13d-1(b)規定進行的，適用於母公司或控股人。貝萊德的主要營業辦公地點列在紐約市10001號哈德遜碼頭50號。總部位於阿拉巴馬州伯明翰市的醫療物業信託公司是涉案普通股的發行方。提交還指出，由貝萊德管理的iShares核心標普小型股ETF持有醫療物業信託公司超過五分之一的未流通普通股。提交披露簽署者是斯賓塞·弗萊明，作爲貝萊德公司的委託代理人，他於2024年11月8日簽署了該文件。
2024年9月30日，貝萊德公司向SEC提交了修訂後的13G/A表，顯示其在醫療物業信託公司擁有重要的所有權股份。提交的文件顯示，貝萊德現在有利地擁有醫療物業信託公司的89,509,007股股份，佔公司普通股的14.9%。該持倉反映了貝萊德對86,853,098股股份的獨家表決權和對整個89,509,007股股份的獨家處置權。該提交是根據1934年證券交易法第13d-1(b)規定進行的，適用於母公司或控股人。貝萊德的主要營業辦公地點列在紐約市10001號哈德遜碼頭50號。總部位於阿拉巴馬州伯明翰市的醫療物業信託公司是涉案普通股的發行方。提交還指出，由貝萊德管理的iShares核心標普小型股ETF持有醫療物業信託公司超過五分之一的未流通普通股。提交披露簽署者是斯賓塞·弗萊明，作爲貝萊德公司的委託代理人，他於2024年11月8日簽署了該文件。
有用
沒用

該公告為獨立文件：

獨立文件1

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間